FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Issues Section 506J Notification Obligation Table

FDA issues a table with recommendations for medical device manufacturers to use in association with an earlier pandemic guidance on notifying the agen...

Human Drugs

Sandoz Sues FDA Over Aubagio NCE Status

Sandoz asks the DC federal court to order FDA to set aside its award of new chemical entity status and exclusivity to Sanofi Genzymes Aubagio and to a...

Human Drugs

Generic Drug Correspondence Guidance Inadequate: AAM

The Association for Accessible Medicines raises several concerns with an FDA final guidance on controlled correspondence related to generic drug-devic...

Medical Devices

Brain Scientifics NeuroCap Cleared

FDA clears a Brain Scientific 510(k) for its NeuroCap device, an advanced electroencephalogram electrode array used to obtain rapid EEGs in routine cl...

Human Drugs

Safety Studies Could Help Galapagos Jyseleca: Report

GlobalData says that positive results from two Jyseleca testicular safety studies could lead to FDA approval for an indication for ulcerative colitis ...

Human Drugs

IND Cleared for Ultragenyx mRNA Therapy

FDA clears an Ultragenyx Pharmaceutical IND for UX053, an investigational mRNA therapy being evaluated for treating Glycogen Storage Disease Type III.

Federal Register

Animal Drug Regs Updated on Review Actions

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug applications and abbreviate...

Medical Devices

CDRH Workshop on Device Consensus Standards

CDRH announces a 4/13 workshop on how medical device developers can use consensus standards in premarket submissions.

Drug Marketing Violation Letters Separated: FDA

CDERs Office of Prescription Drug Promotion no longer maintains an aggregated Web page of recent Warning Letters and Untitled Letters issued to drug m...

Human Drugs

Genentech Withdraws Tecentriq for Urothelial Carcinoma

Genentech says it is withdrawing the U.S. accelerated-approved indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial...